-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK FY2031 Revenue expected to be more than $53.204B vs $45.150B Est

Benzinga·10/28/2026 08:00:29
Listen to the news
GSK (NYSE:GSK) FY2031 Revenue expected to be more than $53.204B vs $45.150B Est